"
Team:SupBiotech-Paris/Biobricks
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 3: | Line 3: | ||
<span style="float: right">[[Team:SupBiotech-Paris/Biobricks#drapeau|Back to top]]</span> | <span style="float: right">[[Team:SupBiotech-Paris/Biobricks#drapeau|Back to top]]</span> | ||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
| + | <html> | ||
| + | <div style="float: right; margin-right: -85px;"> | ||
| + | <a href="https://2009.igem.org/Team:SupBiotech-Paris/Material_%26_Method#drapeau" target="_self"> | ||
| + | <img title="Let's go to the next page !" style="width: 100px;" src="https://static.igem.org/mediawiki/2009/e/e9/Suivant.png";> | ||
| + | </a></div> | ||
| + | </html> | ||
Revision as of 17:29, 14 October 2009
Project
Introduction Current therapies Gene therapies DVS Concept Tissue Vector Cell Vector Therapeutic plasmid Conclusion Implementation Tissue targeting Antitumor action Treatment modeling Conclusion
Ressources
BioBricks Material & Method Bibliography
Ethics & Safety
